Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam benzoate plus alfentanil for spontaneous-breathing fiberoptic bronchoscopy
ChiCTR2200063975Phase 4Recruiting
- Sponsor
- Wuhan No.1 Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and propofol in pulmonary diseases (2 arms), sponsored by Wuhan No.1 Hospital. Primary endpoint: Incidence of respiratory depression. Started Sep 2022; status: recruiting.
02
Drugs
remimazolamalfentanilpropofol
03
Conditions
pulmonary diseases
Beyond the preview
Go deeper on ChiCTR2200063975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063975.